Depo-Provera and its generic equivalents had US sales of around USD 159 million for the 12-month period ending November 2018, Cipla further said.from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2Rk14xx
via IFTTT
Depo-Provera and its generic equivalents had US sales of around USD 159 million for the 12-month period ending November 2018, Cipla further said.
No comments:
Post a Comment